Gianluca Matteoli
gianlucamatteoli.bsky.social
Gianluca Matteoli
@gianlucamatteoli.bsky.social
Prof. Gianluca Matteoli
PI Mucosal Immunology lab
Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven

Advancing innovative therapies for IBD by unraveling stromal-immune system interactions.
We're hiring! 🧪
TARGID @ KU Leuven is looking for a Laboratory Manager to coordinate and support cutting-edge research on gastrointestinal diseases.
📍Leuven | ⏰ Apply by Nov 4, 2025
🔗 kuleuven.be/personeel/jobsite/jobs/60566238
#KULeuven #Hiring #Research
Laboratoriummanager
TARGID zoekt een enthousiaste laboratoriumtechnoloog.
kuleuven.be
October 15, 2025 at 8:04 AM
Reposted by Gianluca Matteoli
Looking for reliable information on fibrosis?

The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian!

Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA!

Download your copy 👉 https://loom.ly/yW8mEBc
August 21, 2025 at 7:30 AM
Reposted by Gianluca Matteoli
NIM lab is growing! 🧠🔬

We are hiring a flow cytometry specialist, a bioinformatician and a post-doc candidate!

Join us or help spread the word:

- jobs.vib.be/j/113480/flo...

- jobs.vib.be/j/113083/bio...

- www.uantwerpen.be/en/jobs/vaca...
May 19, 2025 at 11:27 AM
Reposted by Gianluca Matteoli
Every €1 the EU invests in research can yield up to €11 in growth by 2045.

With €43 billion from Horizon Europe, we’ve backed 15,000+ projects – from antibiotics to the transition.

This year we’ll put in over €7.3 billion to meet Europe’s challenges.

For everyone to benefit ↓

europa.eu/!WHpGGg
May 14, 2025 at 7:02 AM
Delighted to join the International Conference on Complement Therapeutics @aegeanconf.bsky.social — a fantastic setting to hear from pioneers like John Lambris on development of complement-targeted therapies. We will present our latest data on the role of complement in IBD @fibrotarget.bsky.social
May 11, 2025 at 8:55 AM
Reposted by Gianluca Matteoli
Harvard redid its whole homepage to push back against the administration’s demands. I mean, this is just a website but I think it’s kind of a great PR move: www.harvard.edu
Harvard University
Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders who make a difference globally.
www.harvard.edu
April 14, 2025 at 7:10 PM
Reposted by Gianluca Matteoli
April 2025 issue of Trends in Neurosciences:
www.cell.com/issue/S0166-...

Free featured articles & more:
cell.com/trends/neuro...

Cover article: ‘MicroRNA regulation of enteric nervous system development and disease’ by Holland et al., @wboesmans.bsky.social group
www.cell.com/trends/neuro...
April 8, 2025 at 7:17 PM
Fantastic story showcasing the full strength of @KU_Leuven — from cutting-edge basic science to real-world exploitation. A true example of how academic excellence can drive meaningful impact on health! @kuleuvenuniversity.bsky.social
March 28, 2025 at 2:50 PM
Reposted by Gianluca Matteoli
Buongiorno from the @fibrotarget.bsky.social General Assembly meeting in Milan!

It’s been an exciting start to the meeting we’ve already covered advancements in #fibrosis biomarker characterisation, imaging and how to quantify this and began laying the foundation for an upcoming clinical trial!
FIBROTARGET GAM: Day 1 at Humanitas University in Milan

Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆

More soon—stay tuned! 🔍
March 14, 2025 at 10:53 AM
Reposted by Gianluca Matteoli
FIBROTARGET aims to make progress in fibrosis & fibrostenosis research, and encourages patients to join this journey.

Stay informed with our factsheets in 6 different languages!

💡 Learn more: [https://loom.ly/yW8mEBc]

#IBD #FIBROTARGET #PatientImpact #Fibrosis
January 23, 2025 at 1:14 PM
Reposted by Gianluca Matteoli
FIBROTARGET GAM: Day 1 at Humanitas University in Milan

Day 1 highlights:
✅ Patient insights from EFCCA
✅ New fibrosis biomarker research 🔬
✅ Cutting-edge imaging 🏥
✅ Laying the groundwork for a clinical trial 🏆

More soon—stay tuned! 🔍
March 14, 2025 at 9:18 AM
Reposted by Gianluca Matteoli
💫 After two days of insightful discussions, strategic planning, and key project updates, the 3rd FIBROTARGET General Assembly Meeting in Milan is a wrap! 🇮🇹

A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀

#FIBROTARGET #Collaborativeresearch #HorizonEurope
March 14, 2025 at 5:54 PM
Reposted by Gianluca Matteoli
Gender equality doesn’t just 'happen.'

Women’s rights must be fought for and protected.

Our responsibility is clear.

To lead by example and create a world where opportunities are fair for all.

Not just today, but every single day.

#InternationalWomensDay
March 8, 2025 at 8:10 AM
Reposted by Gianluca Matteoli
Francis Collins, the NIH Director for 12 years, led the Human Genome Project and other NIH efforts for 32 years, resigned today. Key words from his resignation letter
www.nytimes.com/2025/03/01/u...
March 1, 2025 at 6:07 PM
Reposted by Gianluca Matteoli
Nature research paper: Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses

https://go.nature.com/3XmyOPD
Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses - Nature
Phagocytosed bacteria can serve as an alternative nutrient source for macrophages, influencing their metabolic and immune responses through the recycling of microbial components, with the process regulated by nutrient-sensing mechanisms and bacterial viability.
go.nature.com
February 27, 2025 at 4:04 PM
Reposted by Gianluca Matteoli
🚨 Join the 5th GGIG Meeting on 15-16 May 2025 in Ghent, highlighting the latest advances in intestinal biology & host-microbe interactions. Honoured to have Prof. Emma Slack
as keynote speaker, and may top-stories from leading scientists in the field. 🦠🔬
www.vibconferences.be/events/5th-g...
5th Ghent Gut Inflammation Group Meeting
15-16 May 2025, Ghent, Belgium Host-microbiota interactions in health and disease
www.vibconferences.be
January 9, 2025 at 2:08 PM
Reposted by Gianluca Matteoli
It’s #MucosalMonday and time for another Mucosal Immunology Podcast episode! This month Cecilia Muglia discusses how colonic polyps in pediatric patients are handled - and what they mean for food allergy. Find it on your favorite platform, including: www.iheart.com/podcast/269-...
Mucosal Immunology Podcast | iHeart
Enjoy enlightening podcasts designed to keep the scientific community up to date with the latest breakthroughs in mucosal immunology. Each episode features cutting-edge research from the Mucosal Immun...
www.iheart.com
February 24, 2025 at 3:27 PM
Reposted by Gianluca Matteoli
Come along for a fantastic feature interview hosted by @marionbrunck.bsky.social, another medical mystery @ashu-mangalam.bsky.social, and the latest #EmergingLeadersinMI research! #MucosalMonday
It’s #MucosalMonday and time for another Mucosal Immunology Podcast episode! This month Cecilia Muglia discusses how colonic polyps in pediatric patients are handled - and what they mean for food allergy. Find it on your favorite platform, including: www.iheart.com/podcast/269-...
Mucosal Immunology Podcast | iHeart
Enjoy enlightening podcasts designed to keep the scientific community up to date with the latest breakthroughs in mucosal immunology. Each episode features cutting-edge research from the Mucosal Immun...
www.iheart.com
February 24, 2025 at 3:47 PM
🎉 600 Years of Excellence: KU Leuven 🎓🌌

This year, KU Leuven celebrates an extraordinary milestone: 600 years of knowledge, innovation, and impact. For six centuries, our university has been at the forefront of education, research, and societal advancement.
February 16, 2025 at 11:27 AM
Reposted by Gianluca Matteoli
What an amazing cover! Congrats @gloglita.bsky.social
February 12, 2025 at 8:54 PM
Reposted by Gianluca Matteoli
"We aim to mobilise a total of €200 billion for AI investments in Europe.

It will be the largest public-private partnership in the world for the development of trustworthy AI."

— President @vonderleyen.ec.europa.eu at the Artificial Intelligence Action Summit
February 11, 2025 at 2:29 PM
Reposted by Gianluca Matteoli
Diversity in Science symposium starting in Leuven!
February 7, 2025 at 8:39 AM
Reposted by Gianluca Matteoli
Deadline Extended to Feb. 15. Abstract Submission and Trainee Award Application - 17th International Conference on #ComplementTherapeutics in #Sissi #Crete #Greece www.aegeanconferences.org/src/App/conf...
February 3, 2025 at 8:49 PM
Reposted by Gianluca Matteoli
🌟 Transforming the future of Crohn’s disease!

UEG is proud to support INTERCEPT IHI project, Europe’s 1st trial using innovative biomarkers to prevent Crohn's before symptoms begin! 🚀

💡 Funded by Innovative Health Initiative - Europe (€38M)
🔗 Learn more: www.intercept-ihi.eu
January 30, 2025 at 12:16 PM
Reposted by Gianluca Matteoli
Our brand new Musocal Immunology Podcast is live! Episode 1 features @regisjoulia.bsky.social chatting with @marionbrunck.bsky.social, @ashu-mangalam.bsky.social, and more @societymucosalimm.bsky.social. Available on Spotify, Apple Podcasts, Amazon Music, and iHeart. www.iheart.com/podcast/269-...
January 27, 2025 at 2:34 PM